Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer Journal Articles Refereed uri icon

Overview

Published in

  • Science Translational Medicine

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1126/scitranslmed.aam7049

Additional Document Info

Parent Title

  • SCIENCE TRANSLATIONAL MEDICINE

Volume

  • 9

Issue

  • 401

Number

  • ARTN eaam7049

Publisher

  • American Association for the Advancement of Science